US biosimilars industry association and non-profit organization the Biosimilars Forum has welcomed Amneal Pharmaceuticals and Meitheal Pharmaceuticals as its newest members.
The two firms will take the membership of the Biosimilars Forum to 10 companies, with Amneal and Meitheal joining a group that already includes Biogen, Boehringer Ingelheim, Coherus BioSciences and
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?